In a previous study, FR+CTC displayed the highest AUC compared with NSE, CEA, CA125, Cyfra21-1, and SCC Ag and could satisfactorily discriminate patients with NSCLC from controls, even in early-stage NSCLC (20). The gene discussed is ENO2; the disease is non-small cell lung carcinoma.